Effect on Insulin Resistance in Tofogliflozin-treated Japanese Type 2 diabetic patients
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000017006
- Lead Sponsor
- Matsuba Medical Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) Has hypersensitivity to tofogliflozin or any other excipient of tofogliflozin 2) With severe ketosis, diabetic coma, or precoma within 6 months 3) With severe infection, pre or post surgery, and serious trauma 4) With severe renal dysfunction 5) With severe liver dysfunction 6) Entered already with another clinical trials (7) Considered as inadequate by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change from baseline in GIR using glucose clamp technique.
- Secondary Outcome Measures
Name Time Method